Tod Brown

Statistics

Publications

Citations

484

H-Index

Active since

1976

Affiliations

Adhera Therapeutics (United States)(Current)

Tod Brown is an author at Adhera Therapeutics (United States) specializing in life sciences, small interfering ribonucleic acids (sirnas), and rna interference.

Publications per year

1976–2011

Publications

The differential effects of human leukocyte pyrogen/lymphocyte-activating factor, T cell growth factor, and interferon on human natural killer activity.

Roy A. Dempsey, C A Dinarello, J W Mier et al. · The Journal of Immunology · 1982 · 138 citations

Life Sciences, Cell Biology, Immunology +17

Pathogenic mechanisms in pulmonary fibrosis: collagen-induced migration inhibition factor production and cytotoxicity mediated by lymphocytes.

Thomas C. Kravis, Aftab Ahmed, Tod Brown et al. · Journal of Clinical Investigation · 1976 · 132 citations · Full text

Medicine, Immunology, Pathology +16

Improved specificity of gene silencing by siRNAs containing unlocked nucleobase analogs

Narendra K. Vaish, Feng Chen, Shaguna Seth et al. · Nucleic Acids Research · 2010 · 109 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

RNAi-based Therapeutics Targeting Survivin and PLK1 for Treatment of Bladder Cancer

Shaguna Seth, Yoshiyuki Matsui, Kathy Fosnaugh et al. · Molecular Therapy · 2011 · 56 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

An Amino Acid-based Amphoteric Liposomal Delivery System for Systemic Administration of siRNA

Roger Adami, Shaguna Seth, Pierrot Harvie et al. · Molecular Therapy · 2011 · 49 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

1–5 of 5